BioLongevity Labs

For foundational recovery support, targeted approaches matter. Train hard—but recover smarter.

Most people respond by pushing harder… But that’s not the solution. The real shift is this: → Support recovery, not just output Because when recovery improves, everything else follows.

Most people think slower recovery is just part of getting older… It’s not. What’s actually changing is how efficiently your body supports its own recovery. And that shift changes everything.

That’s where targeted support comes in. → circulation → tissue function → inflammation balance The shift isn’t training harder. It’s recovering smarter.

Most people accept joint discomfort as inevitable. But your body is constantly trying to repair itself. The issue? Those recovery signals become less efficient over time.

“Wear and tear” is not just aging. It’s often a recovery problem.

LA Weekly just featured BioLongevity Labs. Here’s what they covered and why it’s relevant for the research community. GLP-1 medications have transformed the weight loss landscape. Some studies have observed a portion of weight loss may include lean mass. This has led to increased interest in how different biological pathways are being studied in research settings. At BioLongevity Labs, our team has been studying this area closely. One area of focus is FLGR242 — a recombinant follistatin analog currently under research investigation. FLGR242 is intended for research purposes only. Not for human therapeutic use. As our co-founder @JayCampbell333 explains: “Our product differs from traditional follistatin variants in that it’s a recombinant form with an albumin binder designed to extend half-life.” Key research characteristics of FLGR242: → Extended half-life (~19 days vs ~2 hours in certain follistatin variants) → Albumin-binding design for sustained exposure in research models → Investigated for interaction with myostatin-related pathways → Designed to limit interaction with other signaling proteins As Jay Campbell notes: “It’s a unique compound being explored in muscle-related research pathways.” We’re proud to be featured by LA Weekly as part of the broader scientific conversation around next-generation follistatin research. 🔗 Read the full feature: laweekly.com/biolongevity-l… FLGR242 is for research purposes only.

We made the list. 🏆 BioLongevity Labs has been named to the 2025 Biohacking Index Top 50 by Wellness Eternal — an annual ranking of the most trusted longevity & wellness companies. Based on verified reviews from consumers and practitioners. Not marketing. Real data. See the full report → wellnesseternal.com/top50"

The molecule no one was talking about until now. The Science Times just spotlighted BioLongevity Labs' α-Klotho MAB- our patented, in a deep dive on "inflammaging": the low-grade, chronic inflammation. Researchers have linked cognitive decline, degenerative disease, and accelerated aging. In the words of our co-founder @jaycampbell: "Klotho is arguably one of the strongest anti-aging molecules known to man." What sets α-Klotho MAB apart? A proprietary 29-amino acid albumin-binding construct engineered for improved bioavailability, better stability, prevention of metabolic breakdown, and a controlled extended half-life. Researchers are exploring Klotho's role in antioxidant enzyme activity and inflammatory signaling, two of the most critical pathways in longevity science. For research use only. Link [sciencetimes.com/articles/61442…].

Preseason testing for @BritishF4 season with FORTEC MOTORSPORT LIMITED New to all of the tracks in the UK and the boys 🇺🇸 are running 🔥🔥 Is your business looking for growth!?! Find out how Motorsports is the new networking playground. DM for more information 💵 @iMerchantSolut1 @BioLongevityUSA @CashFelber @Roman_Felber

What is Ipamorelin?

What is Follistatin?

Joe Rogan asks RFK Jr. about peptides.

🚨 BREAKING NEWS: RFK Jr. says ~14 of 19 banned peptides can be legally compounded again by US pharmacies within a few weeks. This will ensure Americans are getting "a good product… from ethical suppliers" vs. black market drug dealers that provide "substandard product" with serious safety risks. The 19 compounds on FDA’s Category 2 compounding safety list include: • BPC-157 • Cathelicidin LL-37 • Emideltide (DSIP) • Epitalon • GHK-Cu (injectable) • GHRP-2 (injectable/nasal) • GHRP-6 • Ipamorelin acetate • Kisspeptin-10 • KPV • Melanotan II • PEG-MGF (pegylated Mechano Growth Factor) • MOTS-C • Semax • Thymosin beta-4 fragment (LKKTETQ) • AOD-9604 • CJC-1295 • Selank acetate (TP-7) • Thymosin-alpha 1 (Ta1) The five least likely to be legalized in a policy shift would be those with the most troubling safety signals or the weakest human data — for example: Melanotan II, Cathelicidin LL-37, GHRP-2, Ipamorelin acetate, and CJC-1295 — because of documented serious adverse events or other red flags in FDA’s risk assessment.

Most 55-year-olds are losing muscle. I gained it in 7 weeks while traveling non-stop. ~ Inconsistent training ~ Constant stress ~ Zero optimal conditions Still got bigger AND leaner simultaneously. Modified follistatin with a 19-day half-life that inhibits myostatin completely. The protocol that breaks biological rules:🧵

Klotho is back in stock, and the best deal is live. Comment DEAL, and I'll send you the deal of today and the direct link to the product.

What is GHK-Cu?

Great podcast with the legendary @daveasprey @JayCampbell333 @felberjosh

What is NAD+?